SPDR S&P Pharmaceuticals ETF (XPH) ETF
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 342.43M |
| Net Asset Value (NAV) | $44.47 |
| Options? | Yes |
| Total Holdings | 47 |
XPH Stock Chart More Charts
XPH Price/Volume Stats
| Current price | $45.70 |
| Prev. close | $44.52 |
| Day low | $44.63 |
| Day high | $45.73 |
| 50-day MA | $47.99 |
| 200-day MA | $44.40 |
| 52-week high | $49.97 |
| 52-week low | $38.71 |
| Volume | 110,700 |
| Avg. volume | 87,123 |
| Dividend yield | 0.54% |
XPH Top Holdings
| Symbol | Company | % of Total |
| ENDP | Endo International Plc | 5.15% |
| LLY | Eli Lilly and Company | 4.9% |
| ZTS | Zoetis Inc. Class A | 4.74% |
| PFE | Pfizer Inc. | 4.7% |
| MRK | Merck & Co. Inc. | 4.65% |
| PRGO | Perrigo Co. Plc | 4.56% |
| AGN | Allergan plc | 4.55% |
| JNJ | Johnson & Johnson | 4.5% |
| JAZZ | Jazz Pharmaceuticals Plc | 4.46% |
| BMY | Bristol-Myers Squibb Company | 4.44% |
XPH Returns
| 1-mo | -4.10% |
| 3-mo | 1.27% |
| 6-mo | 9.92% |
| 1-year | 7.15% |
| 3-year | -5.29% |
| 5-year | 26.47% |
| YTD | 5.36% |
| 2017 | 12.05% |
| 2016 | -23.20% |
| 2015 | -4.62% |
| 2014 | 29.52% |
| 2013 | 60.84% |
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||